Telavancin (Vibativ) for Gram-Positive Skin Infections
Telavancin (Vibativ - Astellas and Theravance), a lipoglycopeptide derivative of vancomycin (Vancocin, and others), has received FDA approval for treatment of complicated skin and skin structure infections caused by susceptible gram-positive bacteria in adults....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Telavancin (Vibativ) for Gram-Positive Skin Infections
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1329
Article Code: 1329a
Date: January 11, 2010
Volume: 52
Pages: 1-2
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1329
Article Code: 1329a
Date: January 11, 2010
Volume: 52
Pages: 1-2
Add this downloadable, electronic article to your cart (U.S. English version only) Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.